|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004340,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0027778,
umls-concept:C0030705,
umls-concept:C0035168,
umls-concept:C0039725,
umls-concept:C0087111,
umls-concept:C0205466,
umls-concept:C0282116,
umls-concept:C0301625,
umls-concept:C0376495,
umls-concept:C0549178,
umls-concept:C0887947,
umls-concept:C1707455,
umls-concept:C2348205,
umls-concept:C2603343
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-7-26
|
|
pubmed:abstractText |
To assess the safety of 2 intermittent treatment strategies compared with continuous therapy for patients with virologic suppression on highly active antiretroviral therapy (HAART) at baseline.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1525-4135
|
|
pubmed:author |
pubmed-author:AnanworanichJintanatJ,
pubmed-author:ApateerapongWichitraW,
pubmed-author:CardielloPeterP,
pubmed-author:CooperDavidD,
pubmed-author:HillAndrewA,
pubmed-author:HirschelBernardB,
pubmed-author:MahanontharitApichaA,
pubmed-author:PhanuphakPraphanP,
pubmed-author:RuxrungthamKiatK,
pubmed-author:SiangphoeUmapornU,
pubmed-author:UbolyamSasiwimolS
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
523-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16044002-Adult,
pubmed-meshheading:16044002-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16044002-Australia,
pubmed-meshheading:16044002-CD4 Lymphocyte Count,
pubmed-meshheading:16044002-Drug Administration Schedule,
pubmed-meshheading:16044002-Female,
pubmed-meshheading:16044002-HIV Infections,
pubmed-meshheading:16044002-HIV-1,
pubmed-meshheading:16044002-Humans,
pubmed-meshheading:16044002-Male,
pubmed-meshheading:16044002-Netherlands,
pubmed-meshheading:16044002-Pilot Projects,
pubmed-meshheading:16044002-RNA, Viral,
pubmed-meshheading:16044002-Thailand
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study.
|
|
pubmed:affiliation |
The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand. jintanat.a@chula.ac.th
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
